What causes hyperkalemia in young adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hyperkalemia in young adults is most commonly caused by medications that decrease potassium excretion, such as renin-angiotensin-aldosterone system inhibitors (RAASi), potassium-sparing diuretics, and NSAIDs, as well as increased potassium intake from supplements or certain foods. According to the most recent and highest quality study 1, medications that may cause hyperkalemia include:

  • Potassium-sparing diuretics (e.g. spironolactone, triamterene, amiloride)
  • Beta-blockers
  • NSAIDs
  • Sacubitril/valsartan
  • Renin-angiotensin-aldosterone inhibitors (RAASi): ACE inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists (MRAs)
  • Direct renin inhibitors (aliskiren)
  • Mannitol
  • Cyclosporine or tacrolimus
  • Pentamidine
  • Trimethoprim-sulfamethoxazole
  • Heparin
  • Digitalis
  • Calcineurin inhibitors
  • Penicillin G Additionally, increased potassium intake from sources such as:
  • Potassium supplements
  • Salt substitute (e.g. DASH)
  • Fruits (bananas, melons, orange juice)
  • Alfalfa
  • Amino acids (aminocaproic acid, arginine, lysine)
  • Dandelion
  • Dried toad skin
  • Hawthorne berry
  • Horsetail
  • Lily of the valley
  • Milkweed
  • Nettle
  • Noni juice
  • Siberian ginseng
  • Stored blood products can also contribute to hyperkalemia. It is essential to note that the incidence of hyperkalemia with RAASi monotherapy is < 2% and increases to 5% with dual RAAS inhibition and to 5–10% when dual therapy is administered in patients with HF or chronic kidney disease 1. A more recent study 1 also highlights the risk of hyperkalemia in patients with chronic kidney disease, diabetes, and heart failure, and in individuals receiving RAASis. Therefore, it is crucial to monitor potassium levels closely in young adults taking these medications or with underlying risk factors.

From the Research

Causes of Hyperkalemia

  • Hyperkalemia is a condition where serum potassium levels exceed 5.5 mmol/l, and it can be caused by various factors, including certain medical conditions, such as chronic kidney disease (CKD), diabetes mellitus, and others 2, 3, 4.
  • Reduced renal excretion, excessive intake, or leakage of potassium from the intracellular space can also lead to hyperkalemia 3, 4.
  • Other conditions that can cause hyperkalemia include hypoaldosteronism, massive tissue breakdown, such as rhabdomyolysis, and the use of certain medications 3, 5, 4.
  • Hyperkalemia can also be caused by transcellular shifts, which can occur due to various factors, including insulin deficiency, metabolic acidosis, and cell lysis 3, 6.

Risk Factors in Young Adults

  • Young adults with chronic kidney disease, diabetes mellitus, or other medical conditions that affect kidney function are at a higher risk of developing hyperkalemia 2, 3, 4.
  • The use of certain medications, such as renin-angiotensin-aldosterone system inhibitors, can also increase the risk of hyperkalemia in young adults 5.
  • A diet high in potassium or the use of potassium supplements can also contribute to the development of hyperkalemia in young adults 6.

Clinical Presentation

  • The symptoms of hyperkalemia are often non-specific and can include muscular weakness, paralysis, and cardiac dysfunction 2, 3, 4.
  • Electrocardiography (ECG) changes can also occur in hyperkalemia, including peaked T waves, widened QRS complexes, and arrhythmias 2, 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.